Latest eczema Stories
Vaccination can lower children's risk of allergy. Cathleen Muche-Borowski and her coauthors present a clinical practice guideline for allergy prevention in the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2009; 106[39]: 625-31).Allergic diseases are becoming increasingly common in Western industrialized countries. As there is still no etiologically based treatment of allergic asthma, hay fever, or atopic eczema, the prevention of these diseases is a matter of...
LUMBY, BC, Oct. 5 /PRNewswire-FirstCall/ - avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the launch of its two week Neuroskin(R) Psoriasis Relief DRTV media test campaign. avVaa World Health Care Products Inc. announced that its two week Neuroskin(R) Psoriasis Relief DRTV media test launched today, October 5, 2009. Over 100...
LUMBY, BC, Oct. 2 /PRNewswire-FirstCall/ - avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the stations that will feature their Neuroskin(R) Psoriasis Relief DRTV commercial during the two week media test. avVaa World Health Care Products Inc. is launching a two week DRTV media test run for Neuroskin(R) Psoriasis Relief beginning the...
LUMBY, BC, Oct. 1 /PRNewswire-FirstCall/ - avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced that they will be launching their second test run of Neuroskin(R) Psoriasis Relief DRTV commercials the week of October 5, 2009. avVaa World Health Care Products will launch a two week DRTV test run for Neuroskin(R) Psoriasis Relief beginning the...
British and Vietnamese scientists say they've discovered parasitic gut worms, such as hookworms, might help prevent and treat asthma and other allergies. Researchers led by Dr. Carsten Flohr of the University of Nottingham, and Dr. Luc Nguyen Tuyen of the Khanh Hoa Provincial Health Service in central Vietnam said their study is the largest double-blind, placebo controlled clinical trial to date looking at potential links between hookworm and other gut worm infections and allergic conditions...
A study conducted in Vietnam has added further weight to the view that parasitic gut worms, such as hookworm, could help in the prevention and treatment of asthma and other allergies.Led by Dr Carsten Flohr, a Clinical Scientist from The University of Nottingham, and Dr Luc Nguyen Tuyen from the Khanh Hoa Provincial Health Service in central Vietnam, the study is the largest double-blind placebo controlled clinical trial to date looking at the potential links between hookworm and other gut...
Researchers at the National Institutes of Health have identified a genetic mutation that accounts for a perplexing condition found in people with an inherited immunodeficiency. The disorder, called combined immunodeficiency, is characterized by a constellation of severe health problems, including persistent bacterial and viral skin infections, severe eczema, acute allergies and asthma, and cancer.The team that made the discovery was led by Helen Su, M.D., Ph.D., at the National Institute of...
NEW YORK, Sept. 3 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Dermatological Therapeutics: Global Markets http://www.reportlinker.com/p0109214/Dermatological-Therapeutics-Global-Markets.html INTRODUCTION STUDY GOALS AND OBJECTIVES BCC's goal in conducting this study was to understand the current status of the U.S. dermatological therapeutics industry and to assess it in the medium term from 2008 through 2013. We were...
BERLIN, September 2 /PRNewswire/ -- - Asset Purchase Agreement Signed for Marketed Prescription Products Desonate(R) and NeoBenz(R) Micro Intendis GmbH, which is part of Bayer HealthCare, announced today that it has signed an agreement to acquire two prescription dermatology product lines from SkinMedica, Inc., a dermatology company based in Carlsbad, CA, USA. Both Desonate(R) and NeoBenz(R) Micro are currently marketed in the U.S. by SkinMedica, Inc. Under the...
LUMBY, BC, Sept. 1 /PRNewswire-FirstCall/ - avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced that it has successfully completed its first week of DRTV 120/60 second test commercials for Neuroskin(R) Psoriasis Relief. Lorie Campbell-Farley, President and COO of avVaa World Health Care Products Inc. stated, "Our first week of testing was to...
